do glp 1 affect bipolar disorder GLP-1 receptor agonists show promise in treating substance use disorders Glp-1 meds and bipolar: any

Intellias NTLA-2001, being developed along with partner Regeneron for the genetic liver disease transthyretin (ATTR) amyloidosis cardiomyopathy, is expected to enter Phase III by the end of this year, Intellia announced

Obesity often helps cause other health problems

The way we titrate GLP-1 medications helps patients do exactly that, losing between 0.5% and 1% of total body weight per week

The most common of these include nausea, vomiting, diarrhea, abdominal pain, and constipation

Nach der aktuellen FLOW-Studie verringert Semaglutid bei Patienten mit T2DM und einer CKD das Risiko klinisch wichtiger Nierenschden und des Todes durch kardiovaskulre Ursachen (10)

Methodology AARP conducted the national online survey of 3,531 Americans 18 and older in November 2024